Advances in diagnostic tools and therapeutic approaches for gliomas: A comprehensive review
Gliomas, a prevalent category of primary malignant brain tumors, pose formidable clinical
challenges due to their invasive nature and limited treatment options. The current …
challenges due to their invasive nature and limited treatment options. The current …
Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages
D Croci, R Santalla Méndez, S Temme… - Science Translational …, 2022 - science.org
High-grade gliomas, the most common and aggressive primary brain tumors, are
characterized by a complex tumor microenvironment (TME). Among the immune cells …
characterized by a complex tumor microenvironment (TME). Among the immune cells …
The brilliance of nanoscience over cancer therapy: Novel promising nanotechnology-based methods for eradicating glioblastoma
Given the limited sensitivity of screening methods and the lack of effective therapeutic
interventions for malignant brain tumors such as glioblastoma multiforme (also known as …
interventions for malignant brain tumors such as glioblastoma multiforme (also known as …
Nuclear Medicine and Cancer Theragnostics: Basic Concepts
V Zoi, M Giannakopoulou, GA Alexiou, P Bouziotis… - Diagnostics, 2023 - mdpi.com
Cancer theragnostics is a novel approach that combines diagnostic imaging and
radionuclide therapy. It is based on the use of a pair of radiopharmaceuticals, one optimized …
radionuclide therapy. It is based on the use of a pair of radiopharmaceuticals, one optimized …
Diagnosis of glioblastoma by immuno-positron emission tomography
E Ruiz-López, J Calatayud-Pérez, I Castells-Yus… - Cancers, 2021 - mdpi.com
Simple Summary Neuroimaging has transformed the way brain tumors are diagnosed and
treated. Although different non-invasive modalities provide very helpful information, in some …
treated. Although different non-invasive modalities provide very helpful information, in some …
Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response
N Vladimirov, O Perlman - International Journal of Molecular Sciences, 2023 - mdpi.com
Immunotherapy constitutes a paradigm shift in cancer treatment. Its FDA approval for several
indications has yielded improved prognosis for cases where traditional therapy has shown …
indications has yielded improved prognosis for cases where traditional therapy has shown …
Drosophila as a toolkit to tackle cancer and its metabolism
H Jiang, T Kimura, H Hai, R Yamamura… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the most severe health problems worldwide accounting for the second
leading cause of death. Studies have indicated that cancers utilize different metabolic …
leading cause of death. Studies have indicated that cancers utilize different metabolic …
Advances in magnetic resonance imaging contrast agents for glioblastoma-targeting theranostics
Glioblastoma (GBM) is the most aggressive malignant brain tumour, with a median survival
of 3 months without treatment and 15 months with treatment. Early GBM diagnosis can …
of 3 months without treatment and 15 months with treatment. Early GBM diagnosis can …
The Circ_0001367/miR-545-3p/LUZP1 Axis regulates cell proliferation, migration and invasion in glioma cells
X Dong, P Zhang, L Liu, H Li, S Cheng, S Li… - Frontiers in …, 2021 - frontiersin.org
Glioma is the most common primary intracranial malignant tumour in adults. It has a high
incidence and poses a serious threat to human health. Circular RNA is a hotspot of cancer …
incidence and poses a serious threat to human health. Circular RNA is a hotspot of cancer …
[HTML][HTML] Targeting glioblastoma through nano-and micro-particle-mediated immune modulation
E Poot, A Maguregui, VG Brunton, D Sieger… - Bioorganic & Medicinal …, 2022 - Elsevier
Glioblastoma Multiforme (GBM) is a multifaceted and complex disease, which has
experienced no changes in treatment for nearly two decades and has a 5-year survival rate …
experienced no changes in treatment for nearly two decades and has a 5-year survival rate …